| Host: |
Rabbit |
| Applications: |
WB/IP |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-IKK Gamma (1-419) is suitable for use in Western Blot and Immunoprecipitation research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000IP 1:50-1:100 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
IKBKG |
| Gene ID: |
8517 |
| Uniprot ID: |
NEMO_HUMAN |
| Immunogen Region: |
1-419 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-419 of human IKK Gamma (NP_003630.1). |
| Immunogen Sequence: |
MNRHLWKSQLCEMVQPSGGP AADQDVLGEESPLGKPAMLH LPSEQGAPETLQRCLEENQE LRDAIRQSNQILRERCEELL HFQASQREEKEFLMCKFQEA RKLVERLGLEKLDLKRQKEQ ALREVEHLKRCQQQMAEDKA SVKAQVTSLLGELQESQSRL EAATKECQALEGRARAASEQ ARQLESEREALQQQHSVQVD QLRMQGQSVEAALRMERQAA SEEKRKLAQLQVAYHQLFQ |
| Tissue Specificity | Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. |
| Post Translational Modifications | Phosphorylation at Ser-68 attenuates aminoterminal homodimerization. Polyubiquitinated on Lys-285 via 'Lys-63'-linked ubiquitin.the ubiquitination is mediated downstream of NOD2 and RIPK2 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Polyubiquitinated on Lys-285 and Lys-399 through 'Lys-63'-linked ubiquitin.the ubiquitination is mediated by BCL10, MALT1 and TRAF6 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway. Monoubiquitinated on Lys-277 and Lys-309.promotes nuclear export. Polyubiquitinated through 'Lys-27' by TRIM23.involved in antiviral innate and inflammatory responses. Linear polyubiquitinated on Lys-111, Lys-143, Lys-226, Lys-246, Lys-264, Lys-277, Lys-285, Lys-292, Lys-302, Lys-309 and Lys-326.the head-to-tail polyubiquitination is mediated by the LUBAC complex and plays a key role in NF-kappa-B activation. Deubiquitinated by USP10 in a TANK-dependent and -independent manner, leading to the negative regulation of NF-kappa-B signaling upon DNA damage. Ubiquitinated at Lys-326 by MARCHF2 following bacterial and viral infection which leads to its degradation. Polyubiquitinated via 'Lys-29'-linked ubiquitin.leading to lysosomal degradation. Sumoylated on Lys-277 and Lys-309 with SUMO1.the modification results in phosphorylation of Ser-85 by ATM leading to a replacement of the sumoylation by mono-ubiquitination on these residues. Neddylated by TRIM40, resulting in stabilization of NFKBIA and down-regulation of NF-kappa-B activity. (Microbial infection) Cleaved by hepatitis A virus (HAV) protease 3C allowing the virus to disrupt the host innate immune signaling. (Microbial infection) Deubiquitinated by Epstein-Barr virus BPLF1 on both 'Lys-48' and 'Lys-63'-linked ubiquitin chains.leading to NF-kappa-B signaling inhibition. (Microbial infection) Polyubiquitinated on Lys-309 and Lys-321 via 'Lys-27'-linked ubiquitin by Shigella flexneri E3 ubiquitin-protein ligase ipah9.8, leading to its degradation by the proteasome. (Microbial infection) Polyubiquitination through 'Lys-63' is interrupted by interaction with SARS coronavirus-2/SARS-CoV-2 virus protein ORF9B which inhibits the NF-kappa-B pathway. |
| Function | Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways. Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin. Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3. Involved in TLR3- and IFIH1-mediated antiviral innate response.this function requires 'Lys-27'-linked polyubiquitination. (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B. |
| Protein Name | Nf-Kappa-B Essential ModulatorNemoFip-3Ikb Kinase-Associated Protein 1Ikkap1Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit GammaI-Kappa-B Kinase Subunit GammaIkk-GammaIkkgIkb Kinase Subunit GammaNf-Kappa-B Essential Modifier |
| Database Links | Reactome: R-HSA-1169091Reactome: R-HSA-1236974Reactome: R-HSA-168638Reactome: R-HSA-168927Reactome: R-HSA-1810476Reactome: R-HSA-202424Reactome: R-HSA-2871837Reactome: R-HSA-445989Reactome: R-HSA-450302Reactome: R-HSA-450321Reactome: R-HSA-4755510Reactome: R-HSA-5357905Reactome: R-HSA-5357956Reactome: R-HSA-5602636Reactome: R-HSA-5603027Reactome: R-HSA-5603029Reactome: R-HSA-5607764Reactome: R-HSA-5684264Reactome: R-HSA-5689880Reactome: R-HSA-5689896Reactome: R-HSA-9020702Reactome: R-HSA-933542Reactome: R-HSA-933543Reactome: R-HSA-937039Reactome: R-HSA-937041Reactome: R-HSA-9705671Reactome: R-HSA-975144Reactome: R-HSA-9758274 |
| Cellular Localisation | CytoplasmNucleusSumoylated Nemo Accumulates In The Nucleus In Response To Genotoxic Stress |
| Alternative Antibody Names | Anti-Nf-Kappa-B Essential Modulator antibodyAnti-Nemo antibodyAnti-Fip-3 antibodyAnti-Ikb Kinase-Associated Protein 1 antibodyAnti-Ikkap1 antibodyAnti-Inhibitor Of Nuclear Factor Kappa-B Kinase Subunit Gamma antibodyAnti-I-Kappa-B Kinase Subunit Gamma antibodyAnti-Ikk-Gamma antibodyAnti-Ikkg antibodyAnti-Ikb Kinase Subunit Gamma antibodyAnti-Nf-Kappa-B Essential Modifier antibodyAnti-IKBKG antibodyAnti-FIP3 antibodyAnti-NEMO antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
